ArticleBMC health services research2026
Beijing's ART insurance coverage: enhancing outpatient visit frequency and reducing out-of-pocket costs.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe incorporation of assisted reproductive technology (ART) into Beijing’s medical insurance (MI) represents a significant policy change aimed at alleviating the declining fertility rates, with unknown effects on outpatient demographics and associated out-of-pocket cost (OOP), which refers to the medical expenses occurred since ART such that patients must cover themselves - within the parameters of the medical insurance catalog-without reimbursement. This study investigates and compares the changes in the demographic characteristics and OOP of outpatient visits before and after the integration of MI for ART.
methodsWe conducted a single-center, retrospective quality improvement study analyzing outpatient medical record data from two 12-month periods: the pre-integration period (July 1, 2022, to June 30, 2023) and the post-integration period (July 1, 2023, to June 30, 2024). Primary outcomes included changes in outpatient visits, insurance coverage distribution, and OOP expenses. Descriptive and comparative analyses were conducted, with potential contributing factors to observed variations briefly explored.
resultsAfter including ART in MI, both outpatient visits and the number of patients significantly increased. The number of patients elevated across all age groups, with the proportion of patients aged 41–42 rising notably, while the proportion of patients under 30 slightly decreased. Urban Employee Basic Medical Insurance (UEBMI) is the predominant insurance type, and the number of patients covered by it increased from 75.22% to 77.59% following the implementation of insurance coverage. The proportion of cross-regional patients surged, with Cross-Region Urban-Rural Resident Basic Medical Insurance (CR-URRBMI) and Cross-Region Urban Employee Basic Medical Insurance (CR-UEBMI) patient proportions increasing to 4.32% and 7.81%, respectively. Although the proportion of infertility patients exhibited a slight decrease, there was an increase in the proportion of patients undergoing intrauterine insemination (AIH). Conversely, the proportion of patients receiving in vitro fertilization/intracytoplamic sperm injection-embryo transfer (IVF/ICSI-ET) treatment saw a decline. Additionally, the OOP associated with outpatient visits experienced a significant drop.
conclusionsMedical mandates for ART coverage were associated with an increase in outpatient visits, particularly drawing in more advanced-age patients and Cross-Region individuals, while simultaneously contributing to a reduction in OOP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.